tchenov Moscow Medical University

Moscow, Russia

tchenov Moscow Medical University

Moscow, Russia
SEARCH FILTERS
Time filter
Source Type

Bojat V.,tchenov Moscow Medical University | Baranov D.S.,tchenov Moscow Medical University | Oganesyan E.A.,tchenov Moscow Medical University | Hamdy Y.M.,tchenov Moscow Medical University | And 2 more authors.
Bulletin of Experimental Biology and Medicine | Year: 2011

Paclitaxel dosage form on nanoparticles of 200-300 nm based on lactic and glycolic acid copolymer was obtained by the co-precipitation method. The possibility of controlled release of paclitaxel at pH 7.4 for 24 h was studied in vitro. Studies on Jurkat/WT human T-lymphoblastic leukemia cells showed that incorporation of paclitaxel in the nanoparticles led to a 4-fold increase of its cytotoxicity (6.8∈×∈10 -6 M) in comparison with paclitaxel solution. The efficiency of compositions containing polysorbate-80 was comparable to that of non-modified nanoparticles containing paclitaxel. © 2011 Springer Science+Business Media, Inc.


PubMed | tchenov Moscow Medical University
Type: Journal Article | Journal: Bulletin of experimental biology and medicine | Year: 2012

Paclitaxel dosage form on nanoparticles of 200-300 nm based on lactic and glycolic acid copolymer was obtained by the co-precipitation method. The possibility of controlled release of paclitaxel at pH 7.4 for 24 h was studied in vitro. Studies on Jurkat/WT human T-lymphoblastic leukemia cells showed that incorporation of paclitaxel in the nanoparticles led to a 4-fold increase of its cytotoxicity (6.810(-6) M) in comparison with paclitaxel solution. The efficiency of compositions containing polysorbate-80 was comparable to that of non-modified nanoparticles containing paclitaxel.

Loading tchenov Moscow Medical University collaborators
Loading tchenov Moscow Medical University collaborators